Click here for Home

  News
  updated 9/17/08

  Resources
     Free
     Premium

  Books/CDs

  Seminars

  Services

  Search

  About Us

  Contact Us

Click here for Home
11/20/2008
Alphabetized Drug List from
8 C.F.R. 1308.11-1308.15
(April 2004)

This is an alphabetical list of the substances contained in the federal schedules (minus the salts, isomers, etc., of the various listed drugs) (current through April 26, 2004).

Updates to the schedules are tracked on the following site:
http://www.deadiversion.usdoj.gov/schedules/actions/90_actions.htm

When the INS bears the burden of proof, the INS cannot remove a noncitizen convicted of a drug offense where the conviction record does not name the controlled substance involved.
See our E-Newsletter on Matter of Paulus, and how to find state controlled substances which are not on the federal list.

Key: Drug Name | (Q) = quantity-based limitation | (A#) = also known as # | (schedule)

*****************************************************************
(-)-1-dimethylamino- 1,2-diphenylethane (A62) (IV),
(-)-delta-9-(trans)-tetrahydrocannabinol] (A58) (III),
(+)-norpseudoephedrine (A61) (IV),
(±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone (A54) (III),
(±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine (A38) (I),
(±)cis-4-methylaminorex (A38) (I),
(±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] (A58) (III),
1 cis or trans tetrahydrocannabinol (A29) (I),
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine (A2) (I),
1-(1-phenylcyclohexyl)-pyrrolidine (A31) (I),
1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine (A10) (I),
1-[1-(2-thienyl)-cyclohexyl]-piperidine (A32) (I),
1-[1-(2-thienyl)cyclohexyl]pyrrolidine (A33) (I),
1-benzylpiperazine (A36) (I),
1-diphenylpropane-carboxylic acid (A46) (II),
1-methyl-4-phenyl-4-propionoxypiperidine (A8) (I),
1-methyl-4-phenylpiperidine-4-carboxylic acid (A50) (II),
1-phenylcyclohexylamine (A53) (II),
1-piperidinocyclohexanecarbonitrile (A53) (II),
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane (A14) (I),
2-(ethylamino)-2-(2-thienyl)-cyclohexanone (A56) (III),
2-(methylamino)-1-phenylpropan-1-one (A37) (I),
2-(methylamino)-propiophenone (A37) (I),
2,5-dimethoxy-4-(n)-propylthiophenethylamine (A17) (I),
2,5-dimethoxy-4-ethylamphet-amine (A16) (I),
2,5-dimethoxyamphetamine (A15) (I),
2,5-dimethoxy-α-methylphenethylamine (A15) (I),
2,5-DMA (A15) (I),
2-amino-1-phenyl-1-propanone (A36) (I),
2-amino-5-phenyl-2-oxazoline (A35) (I),
2-aminopropiophenone (A36) (I),
2C-B (A14) (I),
2C-T-7 (A17) (I),
2-diphenyl-3-methyl-2-propionoxybutane (A59) (IV),
2-methyl-3-morpholino-1 (A46) (II),
2-thienylanalog of phencyclidine (A32) (I),
3-(2-aminobutyl) indole (A12) (I),
3-(2-dimethylaminoethyl)-5-indolol (A23) (I),
3-(β-Dimethylaminoethyl)-5-hydroxyindole (A23) (I),
3, 4 cis or trans tetrahydrocannabinol (A29) (I),
3,4,5-trimethoxy amphetamine (I),
3,4-methylenedioxy amphetamine (I),
3,4-methylenedioxymethamphetamine (A20) (I),
3,4-methylenedioxy-N-ethylamphetamine (A21) (I),
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (A27) (I),
3-Methylfentanyl (A6) (I),
3-methylthiofentanyl (A7) (I),
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one (A57) (III),
4,5-dihydro-5-phenly-2-oxazolamine (A35) (I),
4-bromo-2,5-dimethoxy-amphetamine (A13) (I),
4-Bromo-2,5-dimethoxyphenethylamine (A14) (I),
4-bromo-2,5-dimethoxy-α-methylphenethylamine (A13) (I),
4-bromo-2,5-DMA (A13) (I),
4-cyano-1-methyl-4-phenylpiperidine (A48) (II),
4-cyano-2-dimethylamino-4,4-diphenyl butane (A45) (II),
4-hydroxybutanoic acid (A34) (I),
4-hydroxybutyrate (A34) (I),
4-methoxyamphetamine (A18) (I),
4-methoxy-α-methylphenethylamine (A18) (I),
4-methyl-2,5-dimethoxy-amphetamine (A19) (I),
4-methyl-2,5-dimethoxy-α-methylphenethylamine (A19) (I),
5-hydroxy-N,N-dimethyltryptamine (23) (I),
5-MeO-DIPT (A43) (I),
5-methoxy-3,4-mdthylenedioxy-amphetamine (I),
5-methoxy-N,N-diisopropyltryptamine (A43) (I),
6 cis or trans tetrahydrocannabinol (A29) (I),
7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1[prime],2[prime]:1,2] azepino [5,4-b] indole (A26) (I),
Acetorphine (I),
Acetyl-alpha-methylfentanyl (A1) (I),
Acetyldihydrocodeine (I),
Acetylmethadol (I),
AET (A12) (I),
AL-422 (A37) (I),
AL-463 (A37) (I),
AL-464 (A37) (I),
Alfentanil (II),
Allylprodine (I),
Alpha-(+)-4-dimethylamino-1 (A59) (IV),
Alpha-(methylamino)propiophenone (A37) (I),
Alpha-aminopropiophenone (A36) (I),
Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) (I),
Alpha-desmethyl DOB (A14) (I),
Alpha-ethyltryptamine (A12) (I),
Alphameprodine (I),
Alphamethadol (I),
Alpha-methylfentanyl (A2) (I),
Alpha-methylthiofentanyl (A3)
Alpha-methyltryptamine (A42) (I),
Alpha-N-methylaminopropiophenone (A37) (I),
Alphaprodine (II),
Alprazolam (IV),
Aminorex (A35) (I),
Aminoxaphen (A35) (I),
Amobarbital (II),
Amobarbital (III),
Amphetamine (II),
AMT (A42) (I),
Anabolic Steroids (III),
Anileridine (II),
Barbital (IV),
Barbituric acid (III),
Benzethidine (I),
Benzphetamine (III),
Benzyl (A52) (II),
Benzylfentanyl (A40) (I),
Benzylmorphine (I),
Betacetylmethadol (I),
Beta-hydroxy-3-methylfentanyl (A5) (I),
Beta-hydroxyfentanyl (A4) (I),
Betameprodine (I),
Betamethadol (I),
Betaprodine (I),
Bezitramide (II),
Bromazepam (IV),
Bufotenine (A23) (I),
Bulk dextropropoxyphene (non-dosage forms) (II),
Buprenorphine (III),
Butorphanol (IV),
BZP (A36) (I),
Camazepam (IV),
Cannabis (cannabis plant) (A29) (I),
Carfentanil (II),
Cathine (A61) (IV),
Cathinone (A36) (I),
Chloral betaine (IV),
Chloral hydrate (IV),
Chlordiazepoxide (IV),
Chlorhexadol (III),
Chlorphentermine (III),
Clobazam (IV),
Clonazepam (IV),
Clonitazene (I),
Clorazepate (IV),
Clortermine (III),
Clotiazepam (IV),
Cloxazolam (IV),
Coca leaves (II),
Cocaine (II),
Codeine (II),
Codeine (Q) (V),
Codeine methylbromide (I),
Codeine with active, nonnarcotic ingredients (Q) (III),
Codeine with isoquinoline alkaloid of opium (Q) (III),
Codeine-N-Oxide (I),
Cyclohexamine (A30) (I),
Cyprenorphine (I),
Delorazepam (IV),
Desomorphine (I),
DET (A24) (I),
Dextromoramide (I),
Dextropropoxyphene (A59) (IV),
Diampromide (I),
Diazepam (IV),
Dichloralphenazone (IV),
Diethylpropion (IV),
Diethylthiambutene (I),
Diethyltryptamine (A24) (I),
Difenoxin (I),
Difenoxin and atropine sulfate (Q) (IV),
Difenoxin and atropine sulfate (Q) (V),
Dihydrocodeine (II),
Dihydrocodeine (Q) (V),
Dihydrocodeine with active nonnarcotic ingredients (Q) (III),
Dihydrocodeinone with active nonnarcotic ingredients (Q) (III),
Dihydrocodeinone with isoquinoline alkaloid of opium (Q) (III),
Dihydroetorphine (II),
Dihydromorphine (I),
Dimenoxadol (I),
Dimepheptanol (I),
Dimethyl-9H-dibenzo[b,d]pyran-9-one (A51) (II),
Dimethylthiambutene (I),
Dimethyltryptamine (A25) (I),
Dioxaphetyl butyrate (I),
Diphenoxylate (II),
Diphenoxylate and atropine sulfate (Q) (V),
Dipipanone (I),
DMT (A25) (I),
DOET (A16) (I),
DOM (A19) (I),
Dronabinol (Q) (A58) (III),
Drotebanol (I),
Ecgonine (II),
Ephedrone (A37) (I),
Estazolam (IV),
Ethchlorvynol (IV),
Ethinamate (IV),
Ethyl loflazepate (IV),
Ethyl-4-phenylpiperidine-4-carboxylate (A49) (II),
Ethylamine analog of phencyclidine (A30) (I),
Ethylmethylthiambutene (I),
Ethylmorphine (II),
Ethylmorphine (Q) (V),
Ethylmorphine with active, nonnarcotic ingredients (Q) (III),
Etonitazene (I),
Etorphine (except hydrochloride salt) (I),
Etorphine hydrochloride (II),
Etoxeridine (I),
Etryptamine (A12) (I),
Fencamfamin (IV),
Fenethylline (I),
Fenfluramine (IV),
Fenproporex (IV),
Fentanyl (II),
Fludiazepam (IV),
Flunitrazepam (IV),
Flupyrazapon (A57) (III),
Flurazepam (IV),
Furethidine (I),
Gamma hydroxybutyric acid (III),
Gamma-hydroxybutyrate (A34) (I),
Gamma-hydroxybutyric acid (A34) (I),
GHB (A34) (I),
Glutethimide (II),
Granulated opium (II),
Halazepam (IV),
Haloxazolam (IV),
Heroin (I),
Hydrocodone (II),
Hydromorphinol (I),
Hydromorphone (II),
Hydroxypethidine (I),
Ibogaine (A26) (I),
Isomethadone
Ketamine (A54) (III),
Ketazolam (IV),
Ketobemidone (I),
LAAM (A44) (II),
Levo-alpha-acetylmethadol (A44) (II),
Levo-alphacetylmethadol (A44) (II),
levomethadyl acetate (A44) (II),
Levomethorphan (II),
Levomoramide (I),
Levophenacylmorphan (I),
Levorphanol (II),
Lophophora williamsii Lemaire (A28) (I),
Loprazolam (IV),
Lorazepam (IV),
Lormetazepam (IV),
Lysergic acid (III),
Lysergic acid amide (III),
Lysergic acid diethylamide (I),
Mappine (A23) (I),
Marihuana (I),
Mazindol (IV),
MDE (A21) (I),
MDEA (A21) (I),
MDMA (A20) (I),
Mebutamate (IV),
Mecloqualone (I),
Medazepam (IV),
Mefenorex (IV),
Meperidine (A47) (II),
Mephobarbital (A60) (IV),
Meprobamate (IV),
Mescaline (I),
Metazocine (II),
Methadone (II),
Methadone-Intermediate (A45) (II),
Methamphetamine (II),
Methaqualone (I),
Methcathinone (A37) (I),
Methohexital (IV),
Methyl benzyl ketone (A52) (II),
Methyl ketone (A52) (II),
Methylcathinone (A37) (I),
Methyldesorphine (I),
Methyldihydromorphine (I),
Methylphenidate (II),
Methylphenobarbital (A60) (IV),
Methyprylon (III),
Metopon (II),
Midazolam (IV),
Modafinil (IV),
Monase (A12) (I),
Monomethylpropion (A37) (I),
Moramide-Intermediate (A46) (II),
Morpheridine (I),
Morphine (II),
Morphine methylbromide (I),
Morphine methylsulfonate (I),
Morphine with active, nonnarcotic ingredients (Q) (III),
Morphine-N-Oxide (I),
MPPP (A8) (I),
Myrophine (I),
N-(1-phenylcyclohexyl)ethylamine (A30) (I),
N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide (A9) (I),
N,N-alpha-trimethyl-benzeneethanamine (A39) (I),
N,N-alpha-trimethylphenethylamine (A39) (I),
N,N-Diethyltryptamine (A24) (I),
N,N-dimethylamphetamine (A39) (I),
N,N-dimethylserotonin (23) (I),
N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide (A7) (I),
N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide (A1) (I),
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide (A5) (I),
N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide (A4) (I),
N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (A41) (I),
N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide (A2) (I),
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (A40) (I),
N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide (A3) (I),
N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide (A6) (I),
Nabilone (A51) (II),
Nalorphine (III),
N-Benzylpiperazine (A36) (I),
N-ethyl MDA (A21) (I),
N-ethyl-1-phenylcyclohexylamine(1-phenylcyclohexyl)ethylamine (A30) (I),
N-ethyl-3-piperidyl benzilate (I),
N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine (A21) (I),
N-ethylamphetamine (I),
Nexus (A14) (I),
N-hydroxy MDA (A22) (I),
N-hydroxy-3,4-methylenedioxyamphetamine (A22) (I),
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine (A22) (I),
Nicocodeine (I),
Nicomorphine (I),
Nimetazepam (IV),
Nitrazepam (IV),
N-methyl-3-piperidyl benzilate,
N-methylcathinone (A37) (I),
Noracymethadol (I),
Nordiazepam (IV),
Norephedrone (A36) (I),
Norlevorphanol (I),
Normethadone (I),
Normorphine (I),
Norpipanone (I),
N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide (A11) (I),
Opium (Q) (V),
Opium extracts (II),
Opium fluid (II),
Opium poppy (II),
Opium poppy straw (II),
Opium with active, nonnarcotic ingredients (Q) (III),
Oxazepam (IV),
Oxazolam (IV),
Oxycodone (II),
Oxymorphone (II),
P2P (A52) (II),
Para-fluorofentanyl (A9) (I),
Parahexyl_7374 (A27) (I),
Paraldehyde (IV),
Paramethoxyamphetamine (A18) (I),
PCC (A53) (II),
PCE (A30) (I),
PCPy (A31) (I),
Pemoline (IV),
Pentazocine (IV),
Pentobarbital (II),
Pentobarbital (III),
PEPAP (A10) (I),
Pethidine (A47) (II),
Pethidine-Intermediate-A (A48) (II),
Pethidine-Intermediate-B (A49) (II),
Pethidine-Intermediate-C (A50) (II),
Petrichloral (IV),
Peyote (A28) (I),
Phenadoxone (I),
Phenampromide (I),
Phenanthrene alkaloids of opium poppy (II),
Phenazocine (II),
Phencyclidine (II),
Phendimetrazine (III),
Phenmetrazine (II),
Phenobarbital (IV),
Phenomorphan (I),
Phenoperidine (I),
Phentermine (IV),
Phenyl-2-propanone (A52) (II),
Phenylacetone (A52) (II),
Pholcodine (I),
PHP (A31) (I),
Piminodine (II),
Pinazepam (IV),
Pipradrol (IV),
Piritramide (I),
PMA (A18) (I),
Powdered opium (II),
Prazepam (IV),
Proheptazine (I),
Properidine (I),
Propiram (I),
Psilocybin (I),
Psilocyn (I),
Pyrovalerone (V),
Pyrrolidine analog of phencyclidine (I),
Quazepam (IV),
Racemethorphan (II),
Racemoramide (I),
Racemorphan (II),
Raw opium (II),
Remifentanil (II),
Secobarbital (II),
Secobarbital (III),
Sibutramine (IV),
Sodium oxybate (A34) (I),
Sodium oxybutyrate (A34) (I),
SPA (A62) (IV),
STP (A19) (I),
Sufentanil (II),
Sulfondiethylmethane (III),
Sulfonethylmethane (III),
Sulfonmethane (III),
Synhexyl (A27) (I),
Tabernanthe iboga (A26) (I),
TCP (A32) (I),
TCPy (A33) (I),
Telazol (A55) (III),
Temazepam (IV),
Tetrahydrocannabinols (A29) (I),
Tetrazepam (IV),
Thebacon (I),
Thebaine (II),
Thenylfentanyl (A41) (I),
Thiofentanyl (A11) (I),
Thiophene analog of phencyclidine (A32) (I),
Tiletamine (A56) (III),
Tiletamine plus zolazepam (A55) (III),
Tilidine (I),
Tincture of opium (II),
TPCP (A32) (I),
Triazolam (IV),
Trimeperidine (I),
UR1432 (A37) (I),
Zaleplon (IV),
Zolazepam (A57) (III),
Zolpidem (IV),
α-ET (A12) (I),
α-ethyl-1H-indole-3-ethanamine (A12) (I),

 

     To make an alphabetical proscribed drug list of the specific substances controlled in a specific state, for comparison purposes:

1. Locate the most recent state drug schedule in an electronic format, and paste this list into a word-processor document.

2. Delete all the superfluous language, section headings, etc. so that only a list of the individual drugs remains. Make sure to indicate the schedule in which each drug was listed. Give each drug with multiple names a number, and gave that same number to each A.K.A.

3. Use the "sort" function of the word processor program to alphabetize the federal list.

To make a drug by drug comparison between the California and federal schedules:

4. Paste the Federal alphabetical list into the document that contains the state proscribed drug list.

5. Highlight the state list within the word processor document, and then sort both lists into a single alphabetical listing (with the state drugs still highlighted).

6. Going down the list, use the strikeout function to mark any highlighted/nonhighlighted drug pairs. These pairs each represent a specific controlled substance that appears on both the state and the federal lists. Strike these pairs from the list.

7. Return to the top of the list and use the "find" function to find any AKAs of the drugs stricken. Strike the AKAs.

8. After striking all drugs that are listed on both lists, the substances that remain are those on the state list but which do not appear on the federal controlled substances schedules. A conviction of an offense involving a state drug which is not on the federal list will not trigger deportation.


©2005 Norton Tooby.
All rights reserved.

Home | News | Free Resources | Books/CDs | Seminars
Services
| Search | About Us | Contact Us
Copyright & Disclaimers Policy